海外の治験の状況「1」での検索結果
544件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Follow on Extension of XT-150-1-0201
- Safety and Tolerability;Efficacy
- Australia
- 2018-12-06
Recruiting
- SUBurothelial DUrvalumab injEction-1 (SUBDUE-1)
- Muscle invasive or high risk non muscle invasive bladder cancer; Muscle invasive or high risk non muscle invasive bladder cancer;Cancer - Bladder
- Australia
- 2020-01-24
Recruiting
- Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects
- Bacterial Infections
- Australia
- 2019-05-01
Recruiting
- Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
- Malaria
- Mali
- 2007-02-05
Recruiting
- A Phase I Study for Safety and Tolerability of AL002.
- Healthy;Alzheimer Disease
- Australia, United Kingdom, United States
- 2018-08-15
Recruiting
- The role of glucagon-like peptide-1 (GLP-1) in glycaemic, triglyceride and energy expenditure responses to fat in type 2 diabetes.
- Type 2 diabetes
- Australia
- 2014-10-22
Recruiting
- Nox 1 and 4 inhibition in type 1 diabetic kidney disease
- diabetic kidney disease;type 1 diabetes; diabetic kidney disease type 1 diabetes;Metabolic and Endocrine - Diabetes;Renal and Urogenital - Kidney disease
- Australia
- 2017-08-14
Recruiting
- Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
- Advanced Malignancies;Metastatic Cancer
- Australia, Belgium, Italy, Spain, United States
- 2017-04-19
Recruiting
- This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC 1 or 2
- PFIC1;PFIC2
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom, United States
- 2018-05-25
Recruiting
- Ascending multiple doses of a novel Interluken(IL-1) agonist administered to healthy subjects
- auto-immune inflammatory disease
- Australia
- 2010-04-09